Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.
Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK, Msellati P, Magassouba N, Baize S, Raoul H, Izard S, Kpamou C, March L, Savane I, Barry M, Delaporte E; Postebogui Study Group. Etard JF, et al. Among authors: izard s. Lancet Infect Dis. 2017 May;17(5):545-552. doi: 10.1016/S1473-3099(16)30516-3. Epub 2017 Jan 14. Lancet Infect Dis. 2017. PMID: 28094208
Ocular Complications in Survivors of the Ebola Outbreak in Guinea.
Hereth-Hebert E, Bah MO, Etard JF, Sow MS, Resnikoff S, Fardeau C, Toure A, Ouendeno AN, Sagno IC, March L, Izard S, Lama PL, Barry M, Delaporte E; Postebogui Study Group. Hereth-Hebert E, et al. Among authors: izard s. Am J Ophthalmol. 2017 Mar;175:114-121. doi: 10.1016/j.ajo.2016.12.005. Epub 2016 Dec 18. Am J Ophthalmol. 2017. PMID: 27998698
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group. Ciaffi L, et al. Among authors: izard s. Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28. Lancet HIV. 2017. PMID: 28566227 Clinical Trial.
A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk.
Keita AK, Vidal N, Toure A, Diallo MSK, Magassouba N, Baize S, Mateo M, Raoul H, Mely S, Subtil F, Kpamou C, Koivogui L, Traore F, Sow MS, Ayouba A, Etard JF, Delaporte E, Peeters M; PostEbogui Study Group. Keita AK, et al. Open Forum Infect Dis. 2019 Nov 8;6(12):ofz482. doi: 10.1093/ofid/ofz482. eCollection 2019 Dec. Open Forum Infect Dis. 2019. PMID: 32128327 Free PMC article.
Understanding Long-term Evolution and Predictors of Sequelae of Ebola Virus Disease Survivors in Guinea: A 48-Month Prospective, Longitudinal Cohort Study (PostEboGui).
Diallo MSK, Toure A, Sow MS, Kpamou C, Keita AK, Taverne B, Peeters M, Msellati P, Barry TA, Etard JF, Ecochard R, Delaporte E; PostEboGui Study Group. Diallo MSK, et al. Clin Infect Dis. 2021 Dec 16;73(12):2166-2174. doi: 10.1093/cid/ciab168. Clin Infect Dis. 2021. PMID: 33621316 Free PMC article.
Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.
Diallo MSK, Ayouba A, Keita AK, Thaurignac G, Sow MS, Kpamou C, Barry TA, Msellati P, Etard JF, Peeters M, Ecochard R, Delaporte E, Toure A; PostEbogui Study Group. Diallo MSK, et al. Lancet Microbe. 2021 Dec;2(12):e676-e684. doi: 10.1016/S2666-5247(21)00170-1. Epub 2021 Sep 3. Lancet Microbe. 2021. PMID: 35544108 Free article.
Hepatitis B Virus Prevalence and Vaccination in Men Who Have Sex With Men in West Africa (CohMSM ANRS 12324-Expertise France).
Dah TTE, Couderc C, Coulibaly A, Kouamé MJ, Agboyibor MK, Traoré I, Maradan G, Rojas Castro D, Mensah E, Anoma C, Dembélé Keita B, Spire B, Laurent C; CohMSM Study Group. Dah TTE, et al. Open Forum Infect Dis. 2019 May 23;6(7):ofz249. doi: 10.1093/ofid/ofz249. eCollection 2019 Jul. Open Forum Infect Dis. 2019. PMID: 31281855 Free PMC article.
Men Who Have Sex with Both Men and Women in West Africa: Factors Associated with a High Behavioral Risk of Acquiring HIV from Male Partners and Transmission to Women (CohMSM ANRS 12324-Expertise France).
Fiorentino M, Coulibaly B, Couderc C, Keita BD, Anoma C, Dah E, Mensah E, Aka TN, Touré JR, Camara D, Kokouba AR, Maradan G, Mora M, Bourrelly M, Riegel L, Rojas-Castro D, Spire B, Laurent C, Sagaon-Teyssier L; CohMSM Study Group. Fiorentino M, et al. Arch Sex Behav. 2024 Feb;53(2):757-769. doi: 10.1007/s10508-023-02715-2. Epub 2023 Nov 16. Arch Sex Behav. 2024. PMID: 37973698 Free PMC article.
Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial).
Bousmah MA, Nishimwe ML, Tovar-Sanchez T, Lantche Wandji M, Mpoudi-Etame M, Maradan G, Omgba Bassega P, Varloteaux M, Montoyo A, Kouanfack C, Delaporte E, Boyer S; New Antiretroviral and Monitoring Strategies in HIV-infected Adults in Low-Income Countries (NAMSAL) ANRS 12313 Study Group. Bousmah MA, et al. Pharmacoeconomics. 2021 Mar;39(3):331-343. doi: 10.1007/s40273-020-00987-3. Epub 2020 Dec 23. Pharmacoeconomics. 2021. PMID: 33355914 Free PMC article.
54 results